Capricor Therapeutics (CAPR) Retained Earnings (2010 - 2026)

Capricor Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$253727.0 for Q1 2026.

• In Q1 2026, Retained Earnings fell 114.0% year-over-year to -$253727.0; the TTM figure through Mar 2026 stood at -$253727.0 (down 114.0% YoY), while the FY2025 annual figure was $283154.0, down 72.43% from the prior year.
• Retained Earnings for Q1 2026 stood at -$253727.0, down from $283154.0 in the prior quarter.
• The five-year high for Retained Earnings was $1.8 million in Q1 2025, with the low at -$274.7 million in Q3 2025.
• The 5-year median for Retained Earnings is -$123.0 million (2022), against an average of -$100.8 million.
• Peak annual rise in Retained Earnings reached 335.5% in 2024, while the deepest fall reached 170333.5% in 2024.
• Capricor Therapeutics' Retained Earnings stood at -$137.1 million in 2022, then jumped by 100.17% to $235813.0 in 2023, then jumped by 335.5% to $1.0 million in 2024, then tumbled by 72.43% to $283154.0 in 2025, then sank by 189.61% to -$253727.0 in 2026.
• Business Quant data shows CAPR's Retained Earnings at -$253727.0 in Q1 2026, $283154.0 in Q4 2025, and -$274.7 million in Q3 2025.